Global Cerebral and Tissue Oximetry Devices Market to Grow 6.92% by 2020 - Driven by Incidences of Cerebral Hypoxia - Research and Markets

DUBLIN, July 13, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Cerebral and Tissue Oximetry Devices Market 2016-2020" report to their offering.

The report forecasts the global cerebral and tissue oximetry devices market to grow at a CAGR of 6.92% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Vendors are implementing innovative technologies to develop advanced cerebral and tissue oximeters. Dual-parameter tissue oximeters are one of these innovative devices. These oximeters help in obtaining both pulse and regional oximetry measurements. They offer a side-by-side view of regional oximetry (rSO2), pulse oximetry (SpO2), and pulse rate values in real time for rapid decision making.

According to the report, cerebral hypoxia is becoming prevalent worldwide. The chances of the condition increase in people undergoing cardiovascular, thoracic, and neurological surgeries. These surgeries account for 25%-80% cases of cerebral hypoxia. The condition affects the quality of life and increases hospital stays. Physicians use cerebral and tissue oximeters to monitor the oxygen levels in the brain and prevent mortality due to the condition.

Further, the report states that though cerebral oximeters available in the market employ near-infrared spectroscopy technology to monitor cerebral oxygenation levels, they have certain limitations that restrict their use in medical facilities.

Key vendors:

• CAS Medical Systems Inc.
• Masimo Corp.
• Medtronic plc
• Nonin Medical Inc.

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Cerebral and tissue oximeters: Analysis of approved products

PART 06: Cost and benefit analysis of cerebral and tissue oximeters

PART 07: Market landscape

PART 08: Geographical segmentation

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Appendix

For more information visit http://www.researchandmarkets.com/research/mb9z33/global_cerebral

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call [phone]

For U.S./CAN Toll Free Call [phone]

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]